journal article·2019-12-04Open access

Targeted delivery of poly (methyl methacrylate) particles in colon cancer cells selectively attenuates cancer cell proliferation

Firdos Alam Khan, Sultan Akhtar, Dana Almohazey, Munther Alomari, Sarah Ameen Almofty, Ibrahim Badr, Abdelhamid Elaissari

Abstract

Poly (methyl methacrylate) (PMMA) is basically biocompatible polyester with high resistance to chemical hydrolysis, and high drug permeability and the most important characteristics of PMMA is that it does not produce any toxicity. There is not much information about PMMA action on the colon cancer cells. In the present study, we have synthesized PMMA nanoparticles. The distribution pattern of PMMA particles was analysed by Zeta sizer and the size of the particles was calculated by using quasi elastic light scattering (QELS). The surface structure and the morphology of PMMA were characterized by transmission electron microscope (TEM) and scanning electron microscope (SEM), respectively. We have also analysed their effects on cancerous cells (human colorectal carcinoma cells, HCT-116) and normal, healthy cells (human embryonic kidney cells, HEK-293) by using morphometric, MTT, DAPI and wound healing methods. We report that PMMA particles inhibited the cancer cell viability in a dose-dependent manner. The lower dose (1.0 μg/ml) showed a moderate decrease in cancer cell viability, whereas higher dosages (2.5 μg/ml, 5.0 μg/mL and 7.5 μg/mL) showed steadily decrease in the cancer cell viability. We also report that PMMA is highly selective to cancerous cells (HCT-116), as we did not find any action on the normal healthy cells (HEK-293). In conclusion, our results suggest PMMA particles are potential biomaterials to be used in the treatment of colon cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Orthopaedic implants and arthroplasty

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Stem Cell Biology, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University

Department of Biophysics, Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University

Centre national de la recherche scientifique, LAGEP-UMR 5007, University Claude Bernard Lyon-1, University of Lyon

References (38)

Show source-provided references
1. 10.18632/oncotarget.2237710.18632/oncotarget.22377 ↗
2. 10.3322/caac.2120810.3322/caac.21208 ↗
3. 10.2174/13895570677636140210.2174/138955706776361402 ↗
4. Yaffee P, Osipov A, Tan C, et al. Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol. 2015;6:185–200.
5. 10.1007/s10585-007-9135-110.1007/s10585-007-9135-1 ↗
6. 10.1016/j.ijpharm.2018.02.00710.1016/j.ijpharm.2018.02.007 ↗
7. 10.1080/10937404.2011.61511310.1080/10937404.2011.615113 ↗
8. 10.1038/sj.cdd.440123110.1038/sj.cdd.4401231 ↗
9. 10.1007/s11095-017-2302-410.1007/s11095-017-2302-4 ↗
10. 10.1093/toxsci/kfw01010.1093/toxsci/kfw010 ↗
11. 10.1080/0022293070131493210.1080/00222930701314932 ↗
12. 10.1016/j.envpol.2008.11.00410.1016/j.envpol.2008.11.004 ↗
13. 10.1139/o05-11610.1139/o05-116 ↗
14. Mukherjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 2009;29:3867–3876.
15. 10.1002/adhm.20180081210.1002/adhm.201800812 ↗
16. 10.1007/s10856-016-5796-010.1007/s10856-016-5796-0 ↗
17. 10.1016/j.toxlet.2017.05.01710.1016/j.toxlet.2017.05.017 ↗
18. 10.1039/C8NR02602E10.1039/C8NR02602E ↗
19. 10.1016/j.jconrel.2004.06.02010.1016/j.jconrel.2004.06.020 ↗
20. 10.1016/j.jphotobiol.2018.07.01310.1016/j.jphotobiol.2018.07.013 ↗
21. Gibbens-Bandala BV, Ocampo-García BE, Ferro-Flores G, et al. Multimeric system of RGD-grafted PMMA-nanoparticles as a targeted drug- delivery system for paclitaxel. Curr Pharm Des. 2017;23:3415–3422.
22. 10.1016/j.bios.2018.07.03610.1016/j.bios.2018.07.036 ↗
23. 10.2147/IJN.S12402110.2147/IJN.S124021 ↗
24. 10.2147/IJN.S13475610.2147/IJN.S134756 ↗
25. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
26. 10.1016/S1875-5364(17)30076-610.1016/S1875-5364(17)30076-6 ↗
27. Khan FA, Akhtar S, Almohazey D, et al. Fluorescent magnetic submicronic polymer (FMSP) nanoparticles induce cell death in human colorectal carcinoma cells. Artif Cells Nanomed Biotechnol. 2018;25:1–7.
28. 10.1016/j.bbrc.2017.10.04410.1016/j.bbrc.2017.10.044 ↗
29. 10.1016/j.foodchem.2017.09.08610.1016/j.foodchem.2017.09.086 ↗
30. 10.1016/j.biopha.2017.05.10810.1016/j.biopha.2017.05.108 ↗
31. Sudeep HV, Gouthamchandra K, Venkatesh BJ, et al. Viwithan, a Standardized Withania somnifera root extract induces apoptosis in murine melanoma cells. Pharmacogn Mag. 2018;13:S801–S806.
32. 10.1186/s11658-017-0041-510.1186/s11658-017-0041-5 ↗
33. 10.1016/j.ijpharm.2013.03.03210.1016/j.ijpharm.2013.03.032 ↗
34. 10.2147/PGPM.S5837410.2147/PGPM.S58374 ↗
35. 10.1021/mp300223210.1021/mp3002232 ↗
36. Bianco FJ Jr, Gervasi DC, Tiguert R, et al. Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res. 1998;4:3011–3016.
37. Davies B, Waxman J, Wasan H, et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993;53:5365–5369.
38. 10.1016/j.cellsig.2013.06.00410.1016/j.cellsig.2013.06.004 ↗